Session Information
AABB Annual Meeting & CTTXPO 2011
Click here to go to the previous page
Blood Still Kills: The Benefits of "Dry" Genotype-Matched Red Cell Transfusions 
Track
:
S - Scientific
Program Code:
9116-S
Date:
Saturday, October 22, 2011
Time:
2:00 PM to 3:30 PM
PST
Location:
Ballroom 20BC
DIRECTOR
:
Gregory Denomme, PhD, FCSMLS(D), Director of Immunohematology & Transfusion Services, BloodCenter of Wisconsin
MODERATOR
:
Willy Flegel, MD, Chief, Laboratory Services Section, NIH Clinical Center, Dept Transfusion Medicine
SPEAKER
(S):
Willy Flegel, MD, Chief, Laboratory Services Section, NIH Clinical Center, Dept Transfusion Medicine
Dr. Ellen Klapper, MD, Medical Director, Transfusion Medicine, Cedars Sinai Medical Center, Clincal Professor Department of Pathology and Laboratory Medicine UCLA School of Medicine, Cedars Sinai Medical Center
George Garratty, PhD, FRCPath, Scientific Director, American Red Cross Blood Services
Wendy Paul, MD, Associate Medical Director, Children's National Medical Center
Gregory Denomme, PhD, FCSMLS(D), Director of Immunohematology & Transfusion Services, BloodCenter of Wisconsin
Dr. Christopher Tormey, MD, Associate Professor of Laboratory Medicine, Yale University School of Medicine
Description
Molecular immunohematology is rapidly being adopted in transfusion medicine. Molecular information has lead to advanced care in HDFN, and is a necessary tool for the IRL. Now, molecular immunohematology is poised to address non-ABO hemolytic transfusion reactions including the prevention of alloimmunization through "dry" (genotype) matching, antibody evanescence, and the appropriate support chronic transfusion and marrow transplantation. This education session is designed to challenge the transfusion scientific community to think about the impact that molecular immunohematology has on complex problems in transfusion. How can red cell alloimmunization be addressed? What advantages can be had by "dry" (genotype) matching donor "liquid organs" to patients? How can blood group genotyping be used to improve the support of the chronically transfused patient? Join us for presentations and discussions on leading edge applications in molecular immunohematology.
This session offers Self-Assessment Module (SAM) credit. Please complete the post test to receive SAM credit.
This session offers Self-Assessment Module (SAM) credit. Please complete the post test to receive SAM credit.
LEARNER OUTCOMES:
- Assess the specific needs of transfusion support for patients with sickle cell disease.
- Introduce the concept of molecular "dry" matching for red cell transfusions.
- Provide current information on red cell alloimmunization and antibody evanescence.
- Review the immune hazards of red cell transfusions.
| CE Category | CE Value |
|---|---|
| California Clinical Laboratory Personnel | 1.5 |
| California Nurse | 1.8 |
| Florida Laboratory Personnel | 1.8 |
| General Attendee | 1.5 |
| Physician | 1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.
Online Access
(Code: 9116-S)
Attendee/Member:$25 USD
Attendee/Non-Member:$40 USD
Non-Attendee/Member:$40 USD
Non-Attendee/Non-Member $50 USD - Your Price
This session is a part of:
This session is a part of:
 | Copyright © 2014 by MultiView, Inc. All website graphics, text, design, software, and other works are the copyrighted works of MultiView, Inc. All audio, video, presentation materials, logos and text are the copyrighted works of their respective owners. All Rights Reserved. Any redistribution or reproduction of any materials herein is strictly prohibited. |  |